| Literature DB >> 30144857 |
Balaji Govindaswami1, Priya Jegatheesan2, Matthew Nudelman2, Sudha Rani Narasimhan2.
Abstract
Preterm birth (PTB) rate varies widely and has significant racial and ethnic disparities. Although causal mechanisms are ill understood, socioenvironment, phenotype, and genotype provide insight into pathways for preventing PTB. Data suggest varied response to current medical interventions is explicable Approved by underlying pharmacogenomics. Currently, prevention focuses on minimizing iatrogenic PTB and risk reduction especially in those with prior PTB using proven medical and public health strategies. In the future, preventive approaches will be based on better understanding of sociodemography, nutrition, lifestyles, and underlying individual genetic and epigenetic variation. Statistical approaches and "big-data" models are critical in future study.Keywords: Aspirin; Cerclage; Clindamycin; Clotrimazole; Nifedipine; Preterm birth prevention; Preterm prevention clinic; Progesterone
Mesh:
Substances:
Year: 2018 PMID: 30144857 DOI: 10.1016/j.clp.2018.05.013
Source DB: PubMed Journal: Clin Perinatol ISSN: 0095-5108 Impact factor: 3.430